Arman Qamar MD MPH (@AqamarMD) profile picture

Interventional Cardiology l Vascular Medicine l Clinical Research I NorthShore University Health System

Evanston I Illinois
Joined November 2017
Photo by Arman Qamar MD MPH (@AqamarMD)Photo by Arman Qamar MD MPH (@AqamarMD)Photo by Arman Qamar MD MPH (@AqamarMD)Photo by Arman Qamar MD MPH (@AqamarMD)Photo by Arman Qamar MD MPH (@AqamarMD)
A biomarker risk score approach identifies patients deriving highest absolute benefit from intensive LDL lowering with ezetimibe. @TIMIStudyGroup @rgiugliano @califf001 @cpcannon #EugeneBraunwald #DavidMorrow #IMPROVEIT @precisionfda @HarvardChanSPH onlinejacc.org/content/74/8/…
2
13
2
69
Arman Qamar MD MPH retweeted
Wrapped up an amazing week at #SCAI2025 in Washington, DC! Huge thanks to the incredible mentor, Dr. Arman Qamar for the inspiration and guidance and my research team at MCA and HVRA.
2
4
35
2,596
Exciting opportunity! We’re looking for a Cardiovascular Outcomes Research Fellow to join our team at Endeavor Health. If you’re passionate about advancing CV research & making a real impact, apply now! DM for more details. #Hiring @mj_ricciardi @HeartOTXHeartMD @SripalBangalore
3
7
1
29
4,317
Arman Qamar MD MPH retweeted
Our new work in #Atherosclerosis @ATHjournal studying the association of PAD, CKD and recurrent admissions for ADHF. Special thank you to @CaugheyPhD for her great mentorship! sciencedirect.com/science/ar…
2
5
1
15
5,868
Arman Qamar MD MPH retweeted
Among patients hospitalized w/ ADHF, those w/ concurrent PAD have more prevalent 🫀 comorbidities and higher likelihood of 1-y ADHF readmission, irrespective of CKD status 🔗atherosclerosis-journal.com/… @zainchunawala @DLBHATTMD @AqamarMD @mvaduganathan @robmentz @JLGrodin @CaugheyPhD
1
14
1
20
5,807
Arman Qamar MD MPH retweeted
🔥The #FlowTriever Arm primary endpoint was compared to a performance goal of 32%, based on a published meta-analysis The magnitude of the benefit was so large in #FLAME that investigators stopped the study early to share these outcomes at #ACC23 earlier this year
1
1
1
10
2,535
Arman Qamar MD MPH retweeted
@NorthShoreWeb we’ve become accustomed to @AqamarMD brilliant insights for all things antiplt and anticoag. Nice to see these expert’s views on @TCTMD 💪
1
1
7
462
Great summary on antiplatelet therapy for 2nd-prevention @TCTMD_Yael @HeartOTXHeartMD @mj_ricciardi @NorthShoreWeb
For some 2nd-prevention patients, clopidogrel seems to be superior to aspirin monotherapy after PCI regardless of baseline clinical risk or relative ischemic and bleeding risks, says a post hoc analysis of HOST-EXAM tctmd.com/news/clopidogrel-b… @aqamarmd
2
2
7
3,523
Great #CardioTwitter research showcase @NorthShoreWeb IMED #GrandRounds this morning w @mj_ricciardi , @AqamarMD , and David Davidson. Great team we have here!
1
3
1
6
2,736
Landmark Analysis: Covid 19 Vaccination in India ( covishield and covaxin) doesn’t lead to more heart attack & has protective effect on patients of heart attack. Plos-One 2023. More than 1500 patients. @durgeshjhaTOI @smittal_ips @DLBHATTMD @AqamarMD”@mmamas1973 @ICMRDELHI
2
4
7
1,222
Arman Qamar MD MPH retweeted
Ten current papers for the curious general cardiologist, including ticagrelor monotherapy post PCI, MRA use in cardiac amyloid, asystole post shock from wearable defibs & ⬇️in mortality using telemonitoring in HF Sources: @ESC_Journals, @JACCJournals, @JAMACardio 1/n
12
101
1
293
53,506
Arman Qamar MD MPH retweeted
It was definitely a different era. We were still emerging from the days of POBA, abrupt closure and urgent surgery. We didn’t know what was meaningful in terms of myocardial injury. Easy to say now that PPMI doesn’t matter. In 1990s, many of us were trying to understand it.
Believe it or not, 25 years ago, this was standard of care at many centers. Before 2nd gen (or first gen) DES, potent P2Y12 inhibitors, meaningful use of physiology and imaging, etc. @angioplastyorg @kaulcsmc @DLBHATTMD @HeartBobH
1
1
1
14
11,648
Arman Qamar MD MPH retweeted
Patients presenting with MI but without standard modifiable cardiovascular risk factors may have increased risk of all-cause mortality and lower ️use of guideline directed medical therapy. #AHAJournals @zainchunawala @CaugheyPhD @DLBHATTMD @AqamarMD ahajrnls.org/3OxIxhK
7
1
13
9,528
The PAD Collaborative Quarterly meeting is well underway with a great turnout! Members representing over 25 organizations are joining together to discuss how to improve our understanding of #PAD and how to treat and prevent this disease that affects so many!
1
3
1
16
1,581
Next great debate: Polygenic Risk Score 🆚 CAC @pnatarajanmd 🆚 @MichaelJBlaha Pro PRS: 🥊C-stat is myopic 🥊CAC may tell who won’t benefit from statin 🥊 need more than RF 🥊PRS better at predicting premature events – at Arlington, TX
3
8
38
4,337
Arman Qamar MD MPH retweeted
Top 🔟 Take-Home Points🧵 👇2023 #Guideline for the Management of Patients with Chronic Coronary Disease #CCD 🫀@American_Heart @ACCinTouch @CircAHA @JACCJournals bit.ly/3pYiU0i bit.ly/44wBKL9
8
120
6
322
68,166